The PI3-kinase/Akt activation leading to GSK-3β inactivation has been proposed to play a critical role in myocardial ischemia and compounds that have effects on this pathway may afford cardioprotection [19,20]. The gene discussed is GSK3B; the disease is myocardial ischemia.